关注
Kathryn Stephenson
Kathryn Stephenson
Beth Israel Deaconess Medical Center, Harvard Medical School
在 bidmc.harvard.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Interim results of a phase 1–2a trial of Ad26. COV2. S Covid-19 vaccine
J Sadoff, M Le Gars, G Shukarev, D Heerwegh, C Truyers, AM de Groot, ...
New England Journal of Medicine 384 (19), 1824-1835, 2021
12762021
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
DH Barouch, JB Whitney, B Moldt, F Klein, TY Oliveira, J Liu, ...
Nature 503 (7475), 224-228, 2013
8162013
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
P Abbink, RA Larocca, RA De La Barrera, CA Bricault, ET Moseley, ...
Science 353 (6304), 1129-1132, 2016
5752016
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys
DH Barouch, KE Stephenson, EN Borducchi, K Smith, K Stanley, ...
Cell 155 (3), 531-539, 2013
3752013
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
DH Barouch, FL Tomaka, F Wegmann, DJ Stieh, G Alter, ML Robb, ...
The Lancet 392 (10143), 232-243, 2018
3502018
Immunogenicity of Ad26. COV2. S vaccine against SARS-CoV-2 variants in humans
G Alter, J Yu, J Liu, A Chandrashekar, EN Borducchi, LH Tostanoski, ...
Nature 596 (7871), 268-272, 2021
3472021
Immunogenicity of the Ad26. COV2. S Vaccine for COVID-19
KE Stephenson, M Le Gars, J Sadoff, AM de Groot, D Heerwegh, ...
Jama 325 (15), 1535-1544, 2021
3412021
Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys
EN Borducchi, C Cabral, KE Stephenson, J Liu, P Abbink, D Ng’ang’a, ...
Nature 540 (7632), 284-287, 2016
2992016
Durable humoral and cellular immune responses 8 months after Ad26. COV2. S vaccination
DH Barouch, KE Stephenson, J Sadoff, J Yu, A Chang, M Gebre, ...
New England Journal of Medicine 385 (10), 951-953, 2021
2552021
Vascular disease and thrombosis in SARS-CoV-2-infected rhesus macaques
M Aid, K Busman-Sahay, SJ Vidal, Z Maliga, S Bondoc, C Starke, M Terry, ...
Cell 183 (5), 1354-1366. e13, 2020
2212020
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo …
K Modjarrad, L Lin, SL George, KE Stephenson, KH Eckels, ...
The Lancet 391 (10120), 563-571, 2018
2132018
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting
B Julg, L Dee, J Ananworanich, DH Barouch, K Bar, M Caskey, DJ Colby, ...
The lancet HIV 6 (4), e259-e268, 2019
1822019
HIV-1 neutralizing antibody signatures and application to epitope-targeted vaccine design
CA Bricault, K Yusim, MS Seaman, H Yoon, J Theiler, EE Giorgi, K Wagh, ...
Cell host & microbe 25 (1), 59-72. e8, 2019
1602019
Compassionate use of remdesivir in pregnant women with severe coronavirus disease 2019
RM Burwick, S Yawetz, KE Stephenson, ARY Collier, P Sen, ...
Clinical Infectious Diseases 73 (11), e3996-e4004, 2021
1582021
Zika virus vaccines
P Abbink, KE Stephenson, DH Barouch
Nature Reviews Microbiology 16 (10), 594-600, 2018
1422018
Chikungunya fever
K Bartholomeeusen, M Daniel, DA LaBeaud, P Gasque, RW Peeling, ...
Nature Reviews Disease Primers 9 (1), 17, 2023
1152023
Broadly neutralizing antibodies for HIV eradication
KE Stephenson, DH Barouch
Current Hiv/aids Reports 13, 31-37, 2016
1142016
Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized …
MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ...
Jama 327 (5), 432-441, 2022
1132022
Safety and immunogenicity of the Ad26. COV2. S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial
J Sadoff, ML Gars, G Shukarev, D Heerwegh, C Truyers, AM de Groot, ...
MedRxiv, 2020.09. 23.20199604, 2020
1132020
Vaccines and broadly neutralizing antibodies for HIV-1 prevention
KE Stephenson, K Wagh, B Korber, DH Barouch
Annual review of immunology 38 (1), 673-703, 2020
1022020
系统目前无法执行此操作,请稍后再试。
文章 1–20